USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) shares hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $30.16 and last traded at $30.32, with a volume of 5576 shares trading hands. The stock had previously closed at $30.97.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on USNA shares. DA Davidson boosted their price objective on USANA Health Sciences from $35.00 to $38.00 and gave the company a "neutral" rating in a research note on Thursday, January 2nd. StockNews.com cut USANA Health Sciences from a "strong-buy" rating to a "buy" rating in a report on Friday.
View Our Latest Stock Report on USANA Health Sciences
USANA Health Sciences Trading Up 0.4 %
The firm has a fifty day moving average of $34.42 and a two-hundred day moving average of $37.11. The company has a market capitalization of $604.74 million, a PE ratio of 11.21, a PEG ratio of 0.84 and a beta of 0.87.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of USNA. Pacer Advisors Inc. raised its position in USANA Health Sciences by 16.5% during the 3rd quarter. Pacer Advisors Inc. now owns 544,256 shares of the company's stock valued at $20,638,000 after purchasing an additional 76,904 shares during the last quarter. Pzena Investment Management LLC raised its position in shares of USANA Health Sciences by 7.5% in the 3rd quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company's stock worth $39,801,000 after acquiring an additional 72,977 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of USANA Health Sciences by 7.7% in the 4th quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company's stock worth $27,751,000 after acquiring an additional 55,059 shares in the last quarter. Allspring Global Investments Holdings LLC raised its position in shares of USANA Health Sciences by 14,068.2% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 38,821 shares of the company's stock worth $1,472,000 after acquiring an additional 38,547 shares in the last quarter. Finally, Jane Street Group LLC raised its position in shares of USANA Health Sciences by 330.0% in the 4th quarter. Jane Street Group LLC now owns 39,979 shares of the company's stock worth $1,435,000 after acquiring an additional 30,681 shares in the last quarter. Institutional investors own 54.25% of the company's stock.
USANA Health Sciences Company Profile
(
Get Free Report)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Recommended Stories
Before you consider USANA Health Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.
While USANA Health Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
